263 related articles for article (PubMed ID: 25784270)
21. Plasmacytoid urothelial carcinoma of the bladder: histological and clinical features of 5 cases.
Fritsche HM; Burger M; Denzinger S; Legal W; Goebell PJ; Hartmann A
J Urol; 2008 Nov; 180(5):1923-7. PubMed ID: 18801525
[TBL] [Abstract][Full Text] [Related]
22. Treatment changes and long-term recurrence rates after hexaminolevulinate (HAL) fluorescence cystoscopy: does it really make a difference in patients with non-muscle-invasive bladder cancer (NMIBC)?
Geavlete B; Multescu R; Georgescu D; Jecu M; Stanescu F; Geavlete P
BJU Int; 2012 Feb; 109(4):549-56. PubMed ID: 21711438
[TBL] [Abstract][Full Text] [Related]
23. [Narrow band imaging-assisted cystoscopy in bladder tumor follow-up: Can more tumors be identified?].
Hirner L; Stagge E; Rübben H; Schenck M; Eisenhardt A
Urologe A; 2016 Mar; 55(3):370-5. PubMed ID: 26370096
[TBL] [Abstract][Full Text] [Related]
24. Management of early-invasive high-grade transitional cell carcinoma of the bladder.
Fritsche HM; Burger M
Minerva Urol Nefrol; 2008 Dec; 60(4):265-71. PubMed ID: 18923363
[TBL] [Abstract][Full Text] [Related]
25. Urothelial carcinoma in both adnexa following perforation during transurethral resection of a non-muscle-invasive bladder tumor: a case report and literature review.
Bus MT; Cordeiro ER; Anastasiadis A; Klioueva NM; de la Rosette JJ; de Reijke TM
Expert Rev Anticancer Ther; 2012 Dec; 12(12):1529-36. PubMed ID: 23253219
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of an orthotopic rat bladder urothelial cell carcinoma model by cystoscopy.
Hendricksen K; Molkenboer-Kuenen J; Oosterwijk E; Hulsbergen-van de Kaa CA; Witjes JA
BJU Int; 2008 Apr; 101(7):889-93. PubMed ID: 18201266
[TBL] [Abstract][Full Text] [Related]
27. The impact of frequent cystoscopy on surgical care and cancer outcomes among patients with low-risk, non-muscle-invasive bladder cancer.
Schroeck FR; Lynch KE; Li Z; MacKenzie TA; Han DS; Seigne JD; Robertson DJ; Sirovich B; Goodney PP
Cancer; 2019 Sep; 125(18):3147-3154. PubMed ID: 31120559
[TBL] [Abstract][Full Text] [Related]
28. Recurrence and progression of T1G3 transitional cell carcinoma of the bladder treated with intravesical bacillus Calmette-Guérin.
Günlüsoy B; Değirmenci T; Arslan M; Nergiz N; Minareci S; Ayder AR
Urol Int; 2005; 75(2):107-13. PubMed ID: 16123562
[TBL] [Abstract][Full Text] [Related]
29. Urine cytology in the follow-up of patients with transitional cell carcinoma of the urinary bladder: is that enough as a single method?
Raica M; Miclea F; Ioiart I; Minciu R; Drăgan P
Rom J Morphol Embryol; 1998; 44(1-4):173-8. PubMed ID: 15678859
[TBL] [Abstract][Full Text] [Related]
30. New imaging techniques for nonmuscle invasive bladder cancer.
von Rundstedt FC; Lerner SP
Curr Opin Urol; 2014 Sep; 24(5):532-9. PubMed ID: 25051025
[TBL] [Abstract][Full Text] [Related]
31. [Recurrent transitional cell carcinoma of the bladder in a young woman: report of a case].
Ikeda I; Terao T; Nakagomi K; Masuda M; Hirokawa M
Hinyokika Kiyo; 1992 Nov; 38(11):1261-3. PubMed ID: 1485578
[TBL] [Abstract][Full Text] [Related]
32. Obesity is associated with worse outcomes in patients with T1 high grade urothelial carcinoma of the bladder.
Kluth LA; Xylinas E; Crivelli JJ; Passoni N; Comploj E; Pycha A; Chrystal J; Sun M; Karakiewicz PI; Gontero P; Lotan Y; Chun FK; Fisch M; Scherr DS; Shariat SF
J Urol; 2013 Aug; 190(2):480-6. PubMed ID: 23376707
[TBL] [Abstract][Full Text] [Related]
33. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
34. Value of fluorescence cystoscopy in high risk non-muscle invasive bladder cancer.
Mayr R; Burger M
Curr Urol Rep; 2013 Apr; 14(2):90-3. PubMed ID: 23341375
[TBL] [Abstract][Full Text] [Related]
35. Safety and side effects of immediate instillation of apaziquone following transurethral resection in patients with nonmuscle invasive bladder cancer.
Hendricksen K; Gleason D; Young JM; Saltzstein D; Gershman A; Lerner S; Witjes JA
J Urol; 2008 Jul; 180(1):116-20. PubMed ID: 18485407
[TBL] [Abstract][Full Text] [Related]
36. Lymphovascular invasion of urothelial cancer in matched transurethral bladder tumor resection and radical cystectomy specimens.
Kunju LP; You L; Zhang Y; Daignault S; Montie JE; Lee CT
J Urol; 2008 Nov; 180(5):1928-32; discussion 1932. PubMed ID: 18801529
[TBL] [Abstract][Full Text] [Related]
37. Augmented Bladder Tumor Detection Using Deep Learning.
Shkolyar E; Jia X; Chang TC; Trivedi D; Mach KE; Meng MQ; Xing L; Liao JC
Eur Urol; 2019 Dec; 76(6):714-718. PubMed ID: 31537407
[TBL] [Abstract][Full Text] [Related]
38. Pathologic features of bladder tumors after nephroureterectomy or segmental ureterectomy for upper urinary tract transitional cell carcinoma.
Raman JD; Sosa RE; Vaughan ED; Scherr DS
Urology; 2007 Feb; 69(2):251-4. PubMed ID: 17320658
[TBL] [Abstract][Full Text] [Related]
39. Use of Artificial Intelligence and Machine Learning Algorithms with Gene Expression Profiling to Predict Recurrent Nonmuscle Invasive Urothelial Carcinoma of the Bladder.
Bartsch G; Mitra AP; Mitra SA; Almal AA; Steven KE; Skinner DG; Fry DW; Lenehan PF; Worzel WP; Cote RJ
J Urol; 2016 Feb; 195(2):493-8. PubMed ID: 26459038
[TBL] [Abstract][Full Text] [Related]
40. Management of low grade papillary bladder tumors.
Herr HW; Donat SM; Reuter VE
J Urol; 2007 Oct; 178(4 Pt 1):1201-5; discussion 1205. PubMed ID: 17698090
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
